In vitro studies comparing activities of antimicrobial photodynamic therapy and electrochemically activated solutions

Doctoral thesis English OPEN
Kamil, Z.

Abstract\ud There is a need for alternative “treatments” for killing microbes in wound and other body surfaces. Antimicrobial Photodynamic Therapy (APDT) and Electrochemically Activated Solutions (ECAS) are two recent developments in the field of biocide research that in the future may have widespread applications, replacing conventional antibiotics or disinfectants. The aims of the work described in this thesis are 5-fold. (1) Develop an in vitro model and determine the kill rates of bioluminescent species using bioluminescence light output (2) Measure the comparative effects of heavy water and reactive oxygen species (ROS) inhibitory agents against appropriate controls for both APDT and ECAS treatment and gain insight into general killing mechanisms (3) Develop methods to compare kill rates of target microbe (prokaryotic cells) against mammalian eukaryotic cells, by comparison of kill rates under the same treatment conditions and thus, assess the likelihood of cytotoxic damage to the host (4) Measure the potential of treatments to induce genotoxic damage to mammalian cells using a COMET assay (5) Measure the effects of treatments when the target is growing in biofilm mode (using a continuous matrix perfusion model) and compare standard treatments for fast and slow growing cells.\ud A standard assay was developed containing target cell suspensions with killing agent ECAS or APDT (methylene blue (MB) combined with polychromatic light) and bioluminescence was measured using luminometer and viable count methods. For mechanistic study, the assay was repeated in the presence of ROS scavenger molecules. Fluorescence responses by probes singlet oxygen sensor green (SOSG), 3’-(p-aminophenyl) fluorescein (APF), 3’-(p-hydroxyphenyl) fluorescein (HPF) were measured using a fluorimeter to detect ROS in the presence or absence of specific ROS inhibitory agents. The potential cytotoxicity of APDT and ECAS against keratinocytes (H103) and lymphocytes (Jurkat cell) was measured using the neutral red test (for keratinocytes) and MTS assay (for lymphocytes). Trevigen’s comet assay kit was used to measure genotoxicity produced by ECAS and APDT towards lymphocytes, DNA damage was determined using epifluorescence microscopy. An in vitro flat-bed perfusion biofilm model was used to compare the effects of ECAS and APDT against biofilms, using a low light camera to measure bioluminescence within the biofilm. All data were compared using appropriate statistical analyses. \ud The light output from the bioluminescent target species was highly proportional to the viable counts with high correlation (R2> 0.9). Order of killing susceptibility was S. aureus > E. coli > P. aeruginosa > MRSA. Kill rates measured using luminescent light output from lux-modified target species are more accurate than conventional viable count. The rapid assay method, coupled with the use of D2O, ROS-scavengers and fluorescent probes provided key insights into mechanisms of APDT and ECAS. It was confirmed that singlet oxygen is the main cytotoxic species for ADPT whilst a mixed system (hydroxyl radical plus singlet oxygen, and possibly other species) was involved for ECAS. APDT and ECAS are not particularly cytotoxic to mammalian cells (keratinocytes or lymphocytes); therefore a large safety margin of dose may exist to reduce the microbial cells without harm to mammalian cells. APDT is more genotoxic to lymphocytes than is ECAS but both are less toxic compared to H2O2 positive control. The in vitro flat-bed perfusion biofilm model was suitable to study both APDT and ECAS against biofilm cells. The results showed that biofilm was resistant compared to planktonic cells, and was able to recover easily post treatment. Slower growing cells take longer to recover following APDT.
  • References (69)
    69 references, page 1 of 7

    aeruginosa MCS5-lite. ........................................................................................... 81 Figure 3-4 Growth curves of E. coli Nissle 1917 pGLITE followed by bioluminescence and viable count.. ...................................................................... 82 Figure 3-5 Correlation between bioluminescence of E. coli Nissle 1917 pGLITE and viable count of bacteria in exponential phase of growth ..................................... 83 Figure 3-6 Correlation between bioluminescence and viable counting in bacteria in exponential phase of growth of a suspension of series of log fold dilutions of E.

    coli Nissle 1917 pGLITE.......................................................................................... 84 Figure 3- 7 Kill rates of E. coli Nissle 1917 pGLITE exposed to APDT with different concentrations of MB. ........................................................................................... 87 Figure 3- 8 Reduction of bioluminescence and viable count of E. coli Nissle 1917 pGLITE exposed to APDT compared to controls. .................................................. 88 Costerton, J.W., Stewart, P.S. and Greenberg, E.P. (1999) Bacterial biofilms: a common cause of persistent infections. Science. 284 (5418), pp. 1318-1322.

    Costerton, W., Veeh, R., Shirtliff, M., Pasmore, M., Post, C. and Ehrlich, G. (2003) The application of biofilm science to the study and control of chronic bacterial infections.

    Journal of clinical investigation. 112 (10), pp. 1466-1477.

    (1995) Is there a role for in vivo methylene blue staining in the prediction of bladder tumour recurrence? British Journal of Urology. 75 (4), pp. 477-479.

    Dai, T., Huang, Y. Y. and Hamblin, M. R. (2009) Photodynamic therapy for localized infections-State of the art. Photodiagnosis and Photodynamic Therapy. 6 (3-4), pp.

    Dai, T., Tegos, G.P., Zhiyentayev, T., Mylonakis, E. and Hamblin, M.R. (2010) Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers in Surgery and Medicine. 42 (1), pp. 38-44.

    Daniell, M.D. And Hill, J.S. (1991) A history of photodynamic therapy. The Australian and New Zealand Journal of Surgery. 61(5), pp. 340-348.

    Davies, D. (2003) Understanding biofilm resistance to antibacterial agents. Nature Reviews Drug Discovery. 2 (2), pp. 114-122.

    de Kraker, M.E., Davey, P.G., Grundmann, H. and BURDEN study group (2011) Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe.

  • Metrics
    0
    views in OpenAIRE
    0
    views in local repository
    141
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    UWE Research Repository - IRUS-UK 0 141
Share - Bookmark